Exemestane

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1625 publications

Recurrent Radiation-Induced Angiosarcoma of the Breast Without Distant Metastasis: A Case Report.

Recurrent Radiation-Induced Angiosarcoma of the Breast Without Distant Metastasis: A Case Report.

Journal: Cureus
Published: April 09, 2026

Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.

Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.

Journal: ESMO real world data and digital oncology
Published: April 03, 2026

Outcomes of Anastrozole, Letrozole, and Exemestane in Patients With Postmenopausal Breast Cancer.

Outcomes of Anastrozole, Letrozole, and Exemestane in Patients With Postmenopausal Breast Cancer.

Journal: JAMA network open
Published: February 03, 2026

Imlunestrant (Inluriyo) for advanced breast cancer.

Imlunestrant (Inluriyo) for advanced breast cancer.

Journal: The Medical letter on drugs and therapeutics
Published: January 08, 2026

Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial.

Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial.

Journal: ESMO open
Published: January 05, 2026

Comparison Between Alpelisib Plus Endocrine Therapy and Everolimus Plus Endocrine Therapy After CDK4/6 Inhibitors Progression in Patients with PIK3CA-Mutant Metastatic Breast Cancer: A Single-Center Retrospective Study.

Comparison Between Alpelisib Plus Endocrine Therapy and Everolimus Plus Endocrine Therapy After CDK4/6 Inhibitors Progression in Patients with PIK3CA-Mutant Metastatic Breast Cancer: A Single-Center Retrospective Study.

Journal: Cancers
Published: December 29, 2025

Giredestrant Delivers Long-Sought Adjuvant Benefit.

Giredestrant Delivers Long-Sought Adjuvant Benefit.

Journal: Cancer discovery
Published: December 18, 2025

Screening of Anabolic Androgenic Steroids in Illicit Dietary Supplements and Counterfeit Drugs Using LC-MS/MS and LC-QTOF/MS.

Screening of Anabolic Androgenic Steroids in Illicit Dietary Supplements and Counterfeit Drugs Using LC-MS/MS and LC-QTOF/MS.

Journal: Drug testing and analysis
Published: December 08, 2025

Association study of aromatase inhibitors and adverse events related to osteoporosis: based on pharmacovigilance data.

Association study of aromatase inhibitors and adverse events related to osteoporosis: based on pharmacovigilance data.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 02, 2025

Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study.

Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study.

Journal: Journal of medical Internet research
Published: November 29, 2025

Grade 3 Dermatitis Secondary to Two Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer: A Case Report.

Grade 3 Dermatitis Secondary to Two Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer: A Case Report.

Journal: Cureus
Published: November 25, 2025

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.

Journal: JAMA network open
Published: November 03, 2025
Showing 1-12 of 1,625

Last Updated: 04/28/2026